TY - JOUR
KW - Analgesics, Opioid/adverse effects/therapeutic use
KW - Animals
KW - Buprenorphine/therapeutic use
KW - Female
KW - Humans
KW - Infant, Newborn
KW - Methadone/therapeutic use
KW - Naltrexone/therapeutic use
KW - Neonatal Abstinence Syndrome/diagnosis/drug therapy
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/diagnosis/drug therapy
KW - Pregnancy
KW - Pregnancy Complications/diagnosis/drug therapy
KW - Treatment Outcome
KW - buprenorphine
KW - medically assisted withdrawal
KW - medication-assisted treatment
KW - Methadone
KW - Naltrexone
KW - Neonatal abstinence syndrome
KW - Opioid agonist
KW - Opioid antagonist
KW - opioid use
AU - T. H. Tran
AU - B. L. Griffin
AU - R. H. Stone
AU - K. M. Vest
AU - T. J. Todd
A1 - 
AD - Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois.; Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois.; Pharmacy Practice, University of Georgia College of Pharmacy, Athens, Georgia.; Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois.; Pharmacy Practice, Midwestern University Chicago College of Pharmacy, Downers Grove, Illinois.
BT - Pharmacotherapy
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 7
CY - United States
DO - 10.1002/phar.1958
IS - 7
JF - Pharmacotherapy
M1 - Journal Article
PB - Pharmacotherapy Publications, Inc
PP - United States
PY - 2017
SN - 1875-9114; 0277-0008
SP - 824
EP - 839
EP - 
T1 - Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women
T2 - Pharmacotherapy
TI - Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 28543191
U3 - 10.1002/phar.1958
VL - 37
VO - 1875-9114; 0277-0008
Y1 - 2017
Y2 - Jul
ER -